Ceftazidime Pentahydrate C059-1G

产品介绍

Ceftazidime Pentahydrate is a broad-spectrum, third-generation, β-lactam cephalosporin that interferes with bacterial cell wall synthesis.  Patented in 1979 by Glaxo Group, Ceftazidime came into commercial use in 1984.  Ceftazidime is bactericidal in action exerting its effect by inhibition of enzymes responsible for cell-wall synthesis, primarily penicillin binding protein 3 (PBP3).  Ceftazidime Pentahydrate is sparingly soluble in aqueous solution.